Lab On-Chip and Microarrays Market:
Market Introduction: Global Lab On-Chip and Microarrays Market
Lab on the chip an evolutionary device which integrates single or many laboratory functions on one integrated circuit commonly, a chip. Lab-on-chip generally measures about few square centimetres and used to achieve automation and high through screening. The microarray is the most recent advances in the cancer research. Microarrays help to analyse plenty of samples which have already been recorded or new samples, it even helps to test the incidence of a particular marker in tutors. There are two types of microarrays, gene expression microarrays and tissue microarrays.
Market dynamics: Global Lab On-Chip and Microarrays Market
Global lab on chip and microarrays market is mainly driven by the increase in the adaptation of lab on chip and microarrays in various research fields such as drug discovery, genomics, proteomics and others. In addition, increase in demand for personalized medicine and increase in prevalence rates of cancer that led to the demand for the development of R&D related to cancer diagnostics and treatment expected to boost the global lab on chip and microarrays market over the forecast period. However, a high cost of devices and stringent regulations for research on genomes are expected to hamper the market growth over the forecast period.
Market segmentation: Global Lab On-Chip and Microarrays Market
Global lab-on-chip and microarrays is segmented on basis of type of product and end user
Based on type of product, global lab on chip and microarrays market is segmented into
- PDMS Lab-On-A-Chip
- Thermo Polymers Lab-On-A-Chip
- Glass LAB-ON-A-CHIP
- Silicon Lab-On-A-Chip
- Paper Lab-On-A-Chip
- DNA Microarrays
- Tissue Microarrays
- Protein Microarray
Based on end user, global lab on chip and microarrays market is segmented into
- Biotechnology and Pharmaceutical Firms
- Academic and Research Institutions
- Hospitals and Diagnostic Centres
Market Overview: Global Lab On-Chip and Microarrays Market
The market has very few and dominant players who are actively participating in research and development of the new products. Companies are launching the new products to increase the market share. For instance, in November 2016, Abbott laboratories received CE mark for its innovative blood testing device i-STAT Alinity point of care system, a portable device that can perform and analyse largest menu of blood tests on a single device. Furthermore, companies are collaborating in the development of the new products. For instance, in March 2016, CombiMatrix Molecular Diagnostics (CMDX) and Array Genomics Inc. entered into the collaboration agreement to develop and market a series of comparative genomic hybridization (CGH) microarray products.
Regional overview: Global Lab On-Chip and Microarrays Market
Geographically global Lab On-Chip and Microarrays is segmented as Latin America, Europe, Asia- Pacific, North America, and the Middle East & Africa. North America expected to contribute major growth in global lab-on-chip and microarrays market owing to increase in research and development activities related to cancer and gene sequencing technologies and increase in an adaptation of microarray and lab-on-chip products for diagnosis. Europe is expected to be another major market owing to rising cancer prevalence that leading to the need for the development of reliable and fast diagnostics. Asia Pacific is expected to grow at significant rates owing to the low cost of raw materials and developing healthcare infrastructure.
Market participants: Global Lab On-Chip and Microarrays Market
Some of the key players in global lab on chip and microarrays market are Affymetrix Inc. (U.S.), Abbott Laboratories (U.S.), Agilent Technologies (U.S.), Biomerieux SA (France), Beckman Coulter Inc. (U.S.), and CombiMatrix Molecular Diagnostics (CombiMatrix Corp.) (U.S.) to name a few
Key market developments: Global Lab On-Chip and Microarrays Market
In October 2015, Affymetrix launched new genotype array, The Axiom Transplant Genotype Array, a first array focused on transplant genomics, to help scientists uncover the mechanics of transplant rejection.
Key Features of the Report:
- The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market